ANTIVIRALS - BULEVIRTIDE - 3 MONTHS

This tender is for the procurement of antivirals, specifically Bulevirtide, for a duration of three months. Bulevirtide is a medication used in the treatment of certain viral infections, likely Hepatitis Delta Virus (HDV) infection. The objective is to ensure a continuous supply of this critical medication to patients requiring treatment. The contracting authority is seeking suppliers who can provide the specified antiviral drug in the required quantities and pharmaceutical form. The tender documentation will detail the exact specifications of Bulevirtide needed, including dosage, packaging, and quality standards, as well as the delivery schedule over the three-month period. This procurement is vital for public health and patient care, ensuring that individuals undergoing treatment have uninterrupted access to this essential medicine. Bidders must demonstrate their ability to meet the stringent requirements for pharmaceutical supply.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 19,805.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.